 | Up a level |
Schreiber, Karen; Giles, Ian; Costedoat-Chalumeau, Nathalie; Nelson-Piercy, Catherine; Dolhain, Radboud Jem; Mosca, Marta; Förger, Frauke; Fischer-Betz, Rebecca; Molto, Anna; Tincani, Angela; Pasquier, Elisabeth; Marin, Benoit; Elefant, Elisabeth; Salmon, Jane; Bermas, Bonnie L; Sammaritano, Lisa; Clowse, Megan E B; Chambers, Christina; Buyon, Jill; Inoue, Saori Abe; ... (2023). Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases. The Lancet. Rheumatology, 5(9), e501-e506. Elsevier 10.1016/S2665-9913(23)00215-1
Moor, Matthias B; Suter, Franziska; Hirzel, Cedric; Maurer, Britta; Sidler, Daniel (2022). Cellular responses to SARS-CoV-2 vaccination after B-cell depletion: conflicting results from studies - Authors' reply. The Lancet. Rheumatology, 4(4), e247-e248. Elsevier 10.1016/S2665-9913(22)00035-2
Moor, Matthias B.; Suter-Riniker, Franziska; Horn, Michael P.; Aeberli, Daniel; Amsler, Jennifer; Möller, Burkhard; Njue, Linet M.; Medri, Cesare; Angelillo-Scherrer, Anne; Borradori, Luca; Radonjic-Hoesli, Susanne; Seyed Jafari, S. Morteza; Chan, Andrew; Hoepner, Robert; Bacher, Vera Ulrike; Mani, Laila-Yasmin; Iype, Joseena Mariam; Hirzel, Cédric; Maurer, Britta and Sidler, Daniel (2021). Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study. The Lancet. Rheumatology, 3(11), e789-e797. Elsevier 10.1016/S2665-9913(21)00251-4
Christ, Lisa; Seitz, Luca; Scholz, Godehard; Sarbu, Adela-Cristina; Amsler, Jennifer; Bütikofer, Lukas; Tappeiner, Christoph; Kollert, Florian; Reichenbach, Stephan; Villiger, Peter M. (2021). Tocilizumab monotherapy after ultra-short glucocorticoid administration in giant cell arteritis: a single-arm, open-label, proof-of-concept study. The Lancet. Rheumatology, 3(9), e619-e626. Elsevier 10.1016/S2665-9913(21)00152-1
